TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
90,54 R$
0,00%
(0,00) 1D
6 հոկ, 15:21:39 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TAKP34...
Mkt. cap
59,62 մլրդ
Avg. vol.
36,00
Volume
0,00
52-wk high
102,65 R$
52-wk low
70,80 R$
Shares outstanding
1,60 մլրդ
No. of employees
47 հզր
Mkt. cap
59,62 մլրդ
Avg. vol.
36,00
Volume
0,00
52-wk high
102,65 R$
52-wk low
70,80 R$
Shares outstanding
1,60 մլրդ
No. of employees
47 հզր
News stories
From web sources and news partners
AD HOC NEWS
·
10 ժամ առաջ
Takeda Pharmaceutical stock is unchanged at EUR 16.55 this week
AD HOC NEWS
·
1 ամիս առաջ
Takeda Pharmaceutical stock after-hours at EUR 16.55: unchanged
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd BDR
CEOChristophe Weber | Christophe Weber
Employees47 հզր
Founded12 հնս, 1781 թ.
Headquarters-
Sector-
Websitetakeda.com